HLA-G Free Heavy Chain Protein, Human, Recombinant (His & Avi)

HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells), inhibits the functions of these effectors, and so induces immune inhibition.

Pack Size	Availability	Price/USD
100 μg	5 days	$ 347.00
500 μg	5 days	$ 1,400.00
1 mg	5 days	$ 2,330.00

Pack Size

Availability

Price/USD

Quantity

100 μg

5 days

$ 347.00

500 μg

5 days

$ 1,400.00

1 mg

5 days

$ 2,330.00

Description

Species	Human
Expression System	E. coli
Tag	C-His-Avi
Accession Number	P17693-1
Synonyms	MHC Class I Antigen G, HLA G antigen, HLA-G, sHLA-G, HLA G, b2 microglobulin, MHC class Ib antigen, MHC-G, HLAG
Construction	Recombinant Human HLA-G Free Heavy Chain Protein is expressed from E.coli with His tag and Avi tag at the C-Terminus. It contains Gly25-Thr305(C66S).[Accession \|P17693-1]
Protein Purity	> 95% as determined by Tris-Bis PAGE
Molecular Weight	The protein has a predicted MW of 35.5 kDa. The protein migrates to 36-40 kDa based on Tris-Bis PAGE result.

Endotoxin	Less than 1EU per μg by the LAL method.
Formulation	Supplied as 0.22μm filtered solution in 20mM Tris, 500mM NaCl, 20% Glycerol (pH 8.0).
Stability & Storage	Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Shipping	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Research Background	HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells), inhibits the functions of these effectors, and so induces immune inhibition.